Inotapukira HIV HCV HBSAG UYE Syphilish Rapid Combo Test
MADZIDZO EKUGADZIRA
Model Number | HBsAg/TP&HIV/HCV | Packing | 20 Miedzo / kit, 30kits / CTN |
Zita | HBsAg/TP&HIV/HCV Rapid Combo Test | Instrument classification | Kirasi III |
Features | High senitivity, Easy operation | Chitupa | CE/ ISO13485 |
Kururama | > 97% | Sherufu hupenyu | Makore maviri |
Methodology | Colloidal Gold | OEM / ODM sevhisi | Avaliable |
Superiority
Nguva yekuedza: 15-20mins
Kuchengetedza:2-30℃/36-86℉
Nzira: Colloidal Gold
Feature:
• High sensitive
• mhedzisiro kuverenga mumaminitsi 15-20
• Easy operation
• Kururama kwepamusoro
ZVIRI KUSHANDISA
Iyi kit inokodzera in vitro qualitative determination of hepatitis B virus, syphilis spirochete, human immunodeficiency virus, uye hepatitis C muserum yevanhu/plas-.ma/samples eropa rekuwedzera kuongororwa kwehutachiona hwehepatitis B, syphilis spirochete, human immunodeficiency virus, uye hutachiona hwehepatitis C.Zvigumisiro zvakawanikwa zvinofanirakuongororwa pamwe chete nemamwe mashoko ekiriniki.Inoitirwa kushandiswa nenyanzvi dzekurapa chete.
Test maitiro
1 | Verenga rairo yekushandiswa uye mukunyatso kuenderana nekuraira kwekushandiswa kunodiwa kudzivirira kukanganisa kurongeka kwemhedzisiro yebvunzo. |
2 | Pamberi pekuyedzwa, kiti uye sampu inotorwa kubva munzvimbo yekuchengetera uye yakaenzana kusvika kune tembiricha yekamuri womaka. |
3 | Kubvarura kurongedzerwa kwealuminium foil pouch, buritsa mudziyo wekuyedza womaka, wobva waiisa yakachinjika patafura yekuyedza. |
4 | Aspirate serum / plasma samples ine donhwe rinoraswa uye wedzera madonhwe maviri mune imwe neimwe yematsime s1 uye s2;wedzera madonhwe matatu mune rimwe nerimwe rematsime s1 uye s2 eropa rese resampuli usati wawedzera madonhwe 1 ~ 2 emushonga wekugezesa kune rimwe nerimwe rematsime s1 uye s2 uye Nguva inotanga. |
5 | Mhinduro dzebvunzo dzinofanirwa kududzirwa mukati me15 ~ 20 maminetsi, kana anopfuura maminetsi makumi maviri akaturikirwa mhinduro isiri iyo. |
6 | Kupirikira kunoonekwa kunogona kushandiswa mukududzira kwemhedzisiro. |
Ongorora: imwe neimwe sampu ichapinzwa nepipette yakachena inoraswa kudzivirira kusvibiswa kwemuchinjiko.
KLINICAL PERFORMANCE
WIZ Mibairo yeHBsag
| Muedzo weReference reagent | Yakanaka masangana mwero: 99.06% (95% CI 96.64% ~ 99.74%) Negative coincidence rate: 98.69% (95% CI96.68% ~ 99.49%) Yese masangana mwero:98.84% (95%CI97.50%~99.47% | ||
Positive | Negative | Total | ||
Positve | 211 | 4 | 215 | |
Negative | 2 | 301 | 303 | |
Total | 213 | 305 | 518 |
WIZ Mibairo yeTP
| Muedzo weReference reagent | Yakanaka masangana mwero: 96.18% (95% CI 91.38% ~ 98.36%) Negative coincidence rate: 97.67% (95% CI95.64% ~ 98.77%) Yese masangana mwero: 97.30% (95% CI95.51% ~ 98.38%) | ||
Positive | Negative | Total | ||
Positve | 126 | 9 | 135 | |
Negative | 5 | 378 | 383 | |
Total | 131 | 387 | 518 |
WIZ Mibairo yeHCV
| Muedzo weReference reagent | Yakanaka masangana mwero: 93.44% (95% CI 84.32%~97.42%) Negative coincidence rate: 99.56% (95% CI98.42% ~ 99.88%) Yese masangana mwero:98.84% (95%CI97.50%~99.47%) | ||
Positive | Negative | Total | ||
Positve | 57 | 2 | 59 | |
Negative | 4 | 455 | 459 | |
Total | 61 | 457 | 518 |
WIZ Mibairo yeHIV
| Muedzo weReference reagent | Yakanaka masangana mwero: 96.81% (95%CI 91.03%~98.91%) Negative coincidence rate: 99.76% (95% CI98.68% ~ 99.96%) Yese masangana mwero: 99.23% (95%CI98.03%~99.70%) | ||
Positive | Negative | Total | ||
Positve | 91 | 1 | 92 | |
Negative | 3 | 423 | 446 | |
Total | 94 | 424 | 518 |